Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN05
- Pharmacological subgroupN05C
- Chemical subgroupN05CJ
- Chemical substanceN05CJ02Lemborexant
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
FDA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
6 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Dayvigo | United States | 10MG, 5MG | tablet | Marketed | Eisai INC |
| Dayvigo | Canada | 5 MG | Tablet | Marketed | Eisai Limited |
| Dayvigo | Canada | 10 MG | Tablet | Marketed | Eisai Limited |
| Dayvigo | Brazil | Authorised | Eisai Laboratórios Ltda | ||
| Dayvigo Film-Coated Tablet 10MG | Singapore | 10 mg | tablet, film coated | Authorised | Eisai (Singapore) Pte. LTD. |
| Dayvigo Film-Coated Tablet 5MG | Singapore | 5 mg | tablet, film coated | Authorised | Eisai (Singapore) Pte. LTD. |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of Anvisa, FDA, Health Canada and HSA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.